speb/financial-data huggingface dataset:
JCAP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 37731000.00
JCAP cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 187965000.00
JCAP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 37731000.00
JCAP income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 187965000.00
JCAP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 37731000.00
JCAP income_statement (annual, 2025-12-31) — Net Interest Income: -6223000.00
JCAP income_statement (quarterly, 2025-12-31) — Net Interest Income: -2207000.00
JCAP cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 218502000.00
JCAP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 231584000.00
JCAP cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 218502000.00
JCAP cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 231584000.00
JCAP income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -6223000.00
JCAP income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2207000.00
JCAP cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -15348000.00
JCAP cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -7336000.00
JCAP cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -400858000.00
JCAP cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -280012000.00
JCAP balance_sheet (annual, 2025-12-31) — Net PPE: 1695000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Net PPE: 1695000.00
JCAP cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1085000.00
JCAP cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -440000.00
JCAP balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 411580000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 411580000.00
JCAP balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 101957000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 101957000.00
JCAP balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 101957000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 101957000.00
JCAP income_statement (annual, 2025-12-31) — Normalized EBITDA: 214464000.00
JCAP income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 43002000.00
JCAP income_statement (annual, 2025-12-31) — Normalized Income: 181313775.00
JCAP income_statement (quarterly, 2025-12-31) — Normalized Income: 35882766.00
JCAP cash_flow (annual, 2025-12-31) — Operating Cash Flow: 268813000.00
JCAP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 75168000.00
JCAP income_statement (annual, 2025-12-31) — Operating Income: 216935000.00
JCAP income_statement (quarterly, 2025-12-31) — Operating Income: 44115000.00
JCAP income_statement (annual, 2025-12-31) — Operating Revenue: 613289000.00
JCAP income_statement (quarterly, 2025-12-31) — Operating Revenue: 154799000.00
JCAP balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 58298923.00
JCAP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 58298923.00
JCAP balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 3046000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 3046000.00
JCAP income_statement (annual, 2025-12-31) — Other Gand A: 147395000.00
JCAP income_statement (quarterly, 2025-12-31) — Other Gand A: 40059000.00
JCAP income_statement (annual, 2025-12-31) — Other Income Expense: 7725000.00
JCAP income_statement (quarterly, 2025-12-31) — Other Income Expense: 2161000.00
JCAP balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 6541000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 6541000.00
JCAP cash_flow (annual, 2025-12-31) — Other Non Cash Items: 6223000.00
JCAP cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 2207000.00
JCAP balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 16273000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 16273000.00
JCAP balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 4178000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 4178000.00
JCAP income_statement (annual, 2025-12-31) — Other Operating Expenses: 77200000.00
JCAP income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 21500000.00
JCAP balance_sheet (annual, 2025-12-31) — Other Receivables: 1928742000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1928742000.00
JCAP balance_sheet (annual, 2025-12-31) — Payables: 96063000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Payables: 96063000.00
JCAP balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 96063000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 96063000.00
JCAP income_statement (annual, 2025-12-31) — Pretax Income: 218436000.00
JCAP income_statement (quarterly, 2025-12-31) — Pretax Income: 44116000.00
JCAP income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 2360000.00
JCAP income_statement (quarterly, 2025-12-31) — Provision For Doubtful Accounts: 690000.00
JCAP cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 2360000.00
JCAP cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 690000.00
JCAP cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
JCAP cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1085000.00
JCAP cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -440000.00
JCAP balance_sheet (annual, 2025-12-31) — Receivables: 1957299000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Receivables: 1957299000.00
JCAP income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 164145000.00
JCAP income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 47387000.00
JCAP income_statement (annual, 2025-12-31) — Reconciled Depreciation: 5254000.00
JCAP income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1048000.00
JCAP cash_flow (annual, 2025-12-31) — Repayment Of Debt: -969295000.00
JCAP cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -274423000.00
JCAP balance_sheet (annual, 2025-12-31) — Restricted Cash: 24320000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 24320000.00
JCAP balance_sheet (annual, 2025-12-31) — Retained Earnings: 522632000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 522632000.00
JCAP income_statement (annual, 2025-12-31) — Selling General And Administration: 147395000.00
JCAP income_statement (quarterly, 2025-12-31) — Selling General And Administration: 40059000.00
JCAP balance_sheet (annual, 2025-12-31) — Share Issued: 58298923.00
JCAP balance_sheet (quarterly, 2025-12-31) — Share Issued: 58298923.00
JCAP cash_flow (annual, 2025-12-31) — Stock Based Compensation: 17224000.00
JCAP cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 8374000.00
JCAP balance_sheet (annual, 2025-12-31) — Stockholders Equity: 476135000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 476135000.00
JCAP balance_sheet (annual, 2025-12-31) — Tangible Book Value: 411580000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 411580000.00
JCAP income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 1073775.00
JCAP income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 312766.00
JCAP income_statement (annual, 2025-12-31) — Tax Provision: 30471000.00
JCAP income_statement (quarterly, 2025-12-31) — Tax Provision: 6385000.00
JCAP income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.14
JCAP income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.14
JCAP balance_sheet (annual, 2025-12-31) — Total Assets: 2087373000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Total Assets: 2087373000.00
JCAP balance_sheet (annual, 2025-12-31) — Total Capitalization: 1653591000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1653591000.00
JCAP balance_sheet (annual, 2025-12-31) — Total Debt: 1409040000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Total Debt: 1409040000.00
JCAP balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 476135000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 476135000.00
JCAP income_statement (annual, 2025-12-31) — Total Expenses: 396354000.00
JCAP income_statement (quarterly, 2025-12-31) — Total Expenses: 110684000.00
JCAP balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1611238000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1611238000.00
JCAP balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 82523000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 82523000.00
JCAP balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1283591000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1283591000.00
JCAP income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 316495000.00
JCAP income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 70555000.00
JCAP income_statement (annual, 2025-12-31) — Total Other Finance Cost: 6223000.00
JCAP income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 2207000.00
JCAP balance_sheet (annual, 2025-12-31) — Total Tax Payable: 855000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 855000.00
JCAP income_statement (annual, 2025-12-31) — Total Unusual Items: 7725000.00
JCAP income_statement (quarterly, 2025-12-31) — Total Unusual Items: 2161000.00
JCAP income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 7725000.00
JCAP income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 2161000.00
JCAP balance_sheet (annual, 2025-12-31) — Working Capital: 1677203000.00
JCAP balance_sheet (quarterly, 2025-12-31) — Working Capital: 1677203000.00
JCAP income_statement (quarterly, 2026-03-31) — +Operating Expense: 73901000.00
JCAP income_statement (quarterly, 2026-03-31) — +Total Revenue: 176439000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 89899000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 30238000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: -41024000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1663000.00
JCAP income_statement (quarterly, 2026-03-31) — Basic Average Shares: 55589000.00
JCAP income_statement (quarterly, 2026-03-31) — Basic EPS: 0.61
JCAP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 47551000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3891000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Capital Stock: 6000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 26249000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 26249000.00
JCAP cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
JCAP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -36007000.00
JCAP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -4024000.00
JCAP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 39640000.00
JCAP cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 2190000.00
JCAP cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -20189000.00
JCAP cash_flow (quarterly, 2026-03-31) — Change In Receivables: -2968000.00
JCAP cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -20967000.00
JCAP cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -2968000.00
JCAP cash_flow (quarterly, 2026-03-31) — Changes In Cash: -391000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Common Stock: 6000.00
JCAP cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: 0.00
JCAP balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 442875000.00
JCAP cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -58912000.00
JCAP income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 51310000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Current Assets: 2004915000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Current Debt: 254224000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 254224000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 345056000.00
JCAP cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 11309000.00
JCAP cash_flow (quarterly, 2026-03-31) — Deferred Tax: 11309000.00
JCAP cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 872000.00
JCAP income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 872000.00
JCAP cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 872000.00
JCAP income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 872000.00
JCAP income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 55592000.00
JCAP income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.61
JCAP income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 33797000.00
JCAP income_statement (quarterly, 2026-03-31) — EBIT: 51228000.00
JCAP income_statement (quarterly, 2026-03-31) — EBITDA: 52100000.00
JCAP cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1552000.00
JCAP cash_flow (quarterly, 2026-03-31) — End Cash Position: 45608000.00
JCAP cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -36007000.00
JCAP cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 39640000.00
JCAP income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 1449000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -2655000.00
JCAP income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 42405000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Goodwill: 57915000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 63785000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 31901000.00
JCAP income_statement (quarterly, 2026-03-31) — Gross Profit: 125129000.00
JCAP cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 2330000.00
JCAP cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 28935000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1876196000.00
JCAP cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -4024000.00
JCAP cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 313148000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 254224000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3891000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1179097000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1182988000.00
JCAP cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 313148000.00
JCAP cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -290243000.00
JCAP cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -58912000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Net Debt: 1407072000.00
JCAP income_statement (quarterly, 2026-03-31) — Net Income: 37634000.00
JCAP income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 33797000.00
JCAP income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 37634000.00
JCAP income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 37634000.00
JCAP income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 37634000.00
JCAP cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 37634000.00
JCAP income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 37634000.00
JCAP income_statement (quarterly, 2026-03-31) — Net Interest Income: -1643000.00
JCAP cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 22905000.00
JCAP cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 22905000.00
JCAP income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1643000.00
JCAP cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -4024000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Net PPE: 1490000.00
JCAP cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
JCAP balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 379090000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 113186000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 113186000.00
JCAP income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 50651000.00
JCAP income_statement (quarterly, 2026-03-31) — Normalized Income: 36566087.00
JCAP cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 39640000.00
JCAP income_statement (quarterly, 2026-03-31) — Operating Income: 51228000.00
JCAP income_statement (quarterly, 2026-03-31) — Operating Revenue: 176439000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 55371991.00
JCAP balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -2655000.00
JCAP income_statement (quarterly, 2026-03-31) — Other Gand A: 42405000.00
JCAP income_statement (quarterly, 2026-03-31) — Other Income Expense: 1449000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 5870000.00
JCAP cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1643000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 13915000.00
JCAP income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 30000000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1929069000.00
JCAP income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 3838000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Payables: 90832000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 90832000.00
JCAP income_statement (quarterly, 2026-03-31) — Pretax Income: 51056000.00
JCAP income_statement (quarterly, 2026-03-31) — Provision For Doubtful Accounts: 624000.00
JCAP cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 624000.00
JCAP cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: 0.00
JCAP balance_sheet (quarterly, 2026-03-31) — Receivables: 1959307000.00
JCAP income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 51310000.00
JCAP income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 872000.00
JCAP cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -290243000.00
JCAP cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -58912000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 19359000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 486548000.00
JCAP income_statement (quarterly, 2026-03-31) — Selling General And Administration: 42405000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Share Issued: 55371991.00
JCAP cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8525000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 442875000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 379090000.00
JCAP income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 381087.00
JCAP income_statement (quarterly, 2026-03-31) — Tax Provision: 13422000.00
JCAP income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
JCAP balance_sheet (quarterly, 2026-03-31) — Total Assets: 2084105000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1621972000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Total Debt: 1437212000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 442875000.00
JCAP income_statement (quarterly, 2026-03-31) — Total Expenses: 125211000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1641230000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 79190000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1296174000.00
JCAP income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 80185000.00
JCAP income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 1643000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 933000.00
JCAP income_statement (quarterly, 2026-03-31) — Total Unusual Items: 1449000.00
JCAP income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1449000.00
JCAP balance_sheet (quarterly, 2026-03-31) — Working Capital: 1659859000.00
JCARE.SW cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 3311220.53
JCARE.SW balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 78000000.00
JCARE.SW cash_flow (annual, 2021-12-31) — Sale Of Business: 3311220.53
JCARE.SW balance_sheet (annual, 2021-12-31) — Treasury Stock: 222644454.50
JCARE.SW income_statement (annual, 2022-12-31) — +Operating Expense: 7595252478.73
JCARE.SW income_statement (annual, 2022-12-31) — +Total Revenue: 17142753068.82
JCARE.SW balance_sheet (annual, 2022-12-31) — Accounts Payable: 2579812570.13
JCARE.SW balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3103758850.15
JCARE.SW balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -5640242442.78
JCARE.SW balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2221682284.77
JCARE.SW balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -72476186.71
JCARE.SW cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 190110160.68
JCARE.SW balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 1193958879.05
JCARE.SW income_statement (annual, 2022-12-31) — Basic Average Shares: 189409772.00
JCARE.SW income_statement (annual, 2022-12-31) — Basic EPS: 7.93
JCARE.SW cash_flow (annual, 2022-12-31) — Beginning Cash Position: 11697518141.18
JCARE.SW cash_flow (annual, 2022-12-31) — Capital Expenditure: -1147832255.23
JCARE.SW balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 23482486.07
JCARE.SW balance_sheet (annual, 2022-12-31) — Capital Stock: 1929189374.00
JCARE.SW balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 14808488110.96
JCARE.SW balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 14917503775.94
JCARE.SW cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -389043469.02
JCARE.SW balance_sheet (annual, 2022-12-31) — Cash Equivalents: 15389221.93
JCARE.SW balance_sheet (annual, 2022-12-31) — Cash Financial: 14793098889.03
JCARE.SW cash_flow (annual, 2022-12-31) — Cash Flowsfromusedin Operating Activities Direct: 3977705139.29
JCARE.SW cash_flow (annual, 2022-12-31) — Change In Inventory: -604732283.55
JCARE.SW cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 71951098.72
JCARE.SW cash_flow (annual, 2022-12-31) — Change In Payable: -1924536232.01
JCARE.SW cash_flow (annual, 2022-12-31) — Change In Receivables: 2380941083.00
JCARE.SW cash_flow (annual, 2022-12-31) — Change In Working Capital: -76376333.84
JCARE.SW cash_flow (annual, 2022-12-31) — Changes In Cash: 2291660610.47
JCARE.SW cash_flow (annual, 2022-12-31) — Classesof Cash Payments: -13900993786.17
JCARE.SW cash_flow (annual, 2022-12-31) — Classesof Cash Receiptsfrom Operating Activities: 19299191990.22
JCARE.SW balance_sheet (annual, 2022-12-31) — Common Stock: 1929189374.00
JCARE.SW balance_sheet (annual, 2022-12-31) — Common Stock Equity: 13121955371.22
JCARE.SW balance_sheet (annual, 2022-12-31) — Construction In Progress: 811300068.96
JCARE.SW income_statement (annual, 2022-12-31) — Cost Of Revenue: 6252265308.40
JCARE.SW balance_sheet (annual, 2022-12-31) — Current Assets: 23177507036.65
JCARE.SW balance_sheet (annual, 2022-12-31) — Current Debt: 2126050615.06
JCARE.SW balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2189127876.04
JCARE.SW balance_sheet (annual, 2022-12-31) — Current Liabilities: 9754997731.76
JCARE.SW cash_flow (annual, 2022-12-31) — Depreciation: 647591944.45
JCARE.SW cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 837702105.13
JCARE.SW income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 113223517.86
JCARE.SW income_statement (annual, 2022-12-31) — Depreciation Income Statement: 113223517.86
JCARE.SW income_statement (annual, 2022-12-31) — Diluted Average Shares: 189696684.00
JCARE.SW income_statement (annual, 2022-12-31) — Diluted EPS: 7.92
JCARE.SW balance_sheet (annual, 2022-12-31) — Dividends Payable: 12252074.84
JCARE.SW income_statement (annual, 2022-12-31) — EBIT: 3595121059.61
JCARE.SW income_statement (annual, 2022-12-31) — EBITDA: 4432823164.74
JCARE.SW cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 189286934.75
JCARE.SW cash_flow (annual, 2022-12-31) — End Cash Position: 14178465686.40
JCARE.SW cash_flow (annual, 2022-12-31) — Financing Cash Flow: 566122659.80
JCARE.SW balance_sheet (annual, 2022-12-31) — Finished Goods: 1150353623.19
JCARE.SW cash_flow (annual, 2022-12-31) — Free Cash Flow: 2829872884.06
JCARE.SW cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 20289875.54
JCARE.SW cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 17229947.11
JCARE.SW income_statement (annual, 2022-12-31) — General And Administrative Expense: 276534688.03
JCARE.SW balance_sheet (annual, 2022-12-31) — Goodwill: 614468698.73
JCARE.SW balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1844868708.65
JCARE.SW balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 3176235036.86
JCARE.SW balance_sheet (annual, 2022-12-31) — Gross PPE: 11758585756.62
JCARE.SW income_statement (annual, 2022-12-31) — Gross Profit: 10890487760.42
JCARE.SW income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 142627936.44
JCARE.SW income_statement (annual, 2022-12-31) — Interest Expense: 139016104.44
JCARE.SW income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 139016104.44
JCARE.SW income_statement (annual, 2022-12-31) — Interest Income: 395476309.66
JCARE.SW income_statement (annual, 2022-12-31) — Interest Income Non Operating: 395476309.66
JCARE.SW balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: 0.00
JCARE.SW balance_sheet (annual, 2022-12-31) — Inventory: 2561869999.57
JCARE.SW balance_sheet (annual, 2022-12-31) — Invested Capital: 18478850029.16
JCARE.SW cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2252167188.62
JCARE.SW balance_sheet (annual, 2022-12-31) — Investment Properties: 6191475.43
JCARE.SW balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1193958879.05
JCARE.SW cash_flow (annual, 2022-12-31) — Issuance Of Debt: 5339517086.47
JCARE.SW balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 23482486.07
JCARE.SW balance_sheet (annual, 2022-12-31) — Long Term Debt: 3230844042.88
JCARE.SW balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3254326528.95
JCARE.SW cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 5339517086.47
JCARE.SW cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3718797777.63
JCARE.SW balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 1419882594.59
JCARE.SW balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 5743836061.61
JCARE.SW balance_sheet (annual, 2022-12-31) — Minority Interest: 8898418947.86
JCARE.SW income_statement (annual, 2022-12-31) — Minority Interests: -1391531078.36
JCARE.SW income_statement (annual, 2022-12-31) — Net Income: 1502777133.76
JCARE.SW income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1502777133.76
JCARE.SW income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 2894308212.12
JCARE.SW income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1502777133.76
JCARE.SW income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1502777133.76
JCARE.SW cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 2894308212.12
JCARE.SW income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 2894308212.12
JCARE.SW income_statement (annual, 2022-12-31) — Net Interest Income: 247984483.21
JCARE.SW cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -827198.80
JCARE.SW cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1620719308.84
JCARE.SW cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 1620719308.84
JCARE.SW income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 247984483.21
JCARE.SW cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 296398019.50
JCARE.SW cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -1106604560.18
JCARE.SW balance_sheet (annual, 2022-12-31) — Net PPE: 6118343313.84
JCARE.SW cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1144735429.64
JCARE.SW balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 11277086662.57
JCARE.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 277867716.95
JCARE.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 384537267.55
JCARE.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 540037823.56
JCARE.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 237193884.37
JCARE.SW income_statement (annual, 2022-12-31) — Normalized EBITDA: 4655930859.49
JCARE.SW income_statement (annual, 2022-12-31) — Normalized Income: 1689618228.43
JCARE.SW cash_flow (annual, 2022-12-31) — Operating Cash Flow: 3977705139.29
JCARE.SW income_statement (annual, 2022-12-31) — Operating Income: 3295235281.69
JCARE.SW income_statement (annual, 2022-12-31) — Operating Revenue: 17142753068.82
JCARE.SW balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1929189374.00
JCARE.SW cash_flow (annual, 2022-12-31) — Other Cash Paymentsfrom Operating Activities: -5911684265.17
JCARE.SW cash_flow (annual, 2022-12-31) — Other Cash Receiptsfrom Operating Activities: 683645734.39
JCARE.SW balance_sheet (annual, 2022-12-31) — Other Current Assets: 217588511.43
JCARE.SW balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 101276714.35
JCARE.SW balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1230400009.92
JCARE.SW balance_sheet (annual, 2022-12-31) — Other Inventories: 139989774.33
JCARE.SW cash_flow (annual, 2022-12-31) — Other Non Cash Items: 86666801.37
JCARE.SW balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1156772182.99
JCARE.SW balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 84000000.00
JCARE.SW income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -24443170.68
JCARE.SW income_statement (annual, 2022-12-31) — Other Operating Expenses: 232013172.87
JCARE.SW balance_sheet (annual, 2022-12-31) — Other Payable: 4241092857.50
JCARE.SW balance_sheet (annual, 2022-12-31) — Other Properties: 898395607.03
JCARE.SW balance_sheet (annual, 2022-12-31) — Other Receivables: 2012520756.99
JCARE.SW balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 109015664.98
JCARE.SW income_statement (annual, 2022-12-31) — Other Special Charges: 705357.30
JCARE.SW income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
JCARE.SW balance_sheet (annual, 2022-12-31) — Payables: 7170859776.20
JCARE.SW cash_flow (annual, 2022-12-31) — Paymentson Behalfof Employees: -2260612483.52
JCARE.SW cash_flow (annual, 2022-12-31) — Paymentsto Suppliersfor Goodsand Services: -5728697037.48
JCARE.SW balance_sheet (annual, 2022-12-31) — Prepaid Assets: 364265142.57
JCARE.SW income_statement (annual, 2022-12-31) — Pretax Income: 3456104955.17
JCARE.SW balance_sheet (annual, 2022-12-31) — Properties: 4305054019.02
JCARE.SW cash_flow (annual, 2022-12-31) — Purchase Of Investment: -416183775.89
JCARE.SW cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1147832255.23
JCARE.SW balance_sheet (annual, 2022-12-31) — Raw Materials: 687646673.79
JCARE.SW cash_flow (annual, 2022-12-31) — Receiptsfrom Customers: 18615546255.83
JCARE.SW income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 6252265308.40
JCARE.SW income_statement (annual, 2022-12-31) — Reconciled Depreciation: 837702105.13
JCARE.SW cash_flow (annual, 2022-12-31) — Repayment Of Debt: -3718797777.63
JCARE.SW income_statement (annual, 2022-12-31) — Research And Development: 1742088079.94
JCARE.SW balance_sheet (annual, 2022-12-31) — Retained Earnings: 8456778287.49
JCARE.SW cash_flow (annual, 2022-12-31) — Sale Of Investment: 415356577.09
JCARE.SW cash_flow (annual, 2022-12-31) — Sale Of PPE: 3096825.59
JCARE.SW income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 4493927245.30
JCARE.SW income_statement (annual, 2022-12-31) — Selling General And Administration: 4770461933.33
JCARE.SW balance_sheet (annual, 2022-12-31) — Share Issued: 1929189374.00
JCARE.SW income_statement (annual, 2022-12-31) — Special Income Charges: -147457037.11
JCARE.SW balance_sheet (annual, 2022-12-31) — Stockholders Equity: 13121955371.22
JCARE.SW balance_sheet (annual, 2022-12-31) — Tangible Book Value: 11277086662.57
JCARE.SW income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -36266600.08
JCARE.SW income_statement (annual, 2022-12-31) — Tax Provision: 561796743.05
JCARE.SW income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.16
JCARE.SW cash_flow (annual, 2022-12-31) — Taxes Refund Paid Direct: -1420493064.76
JCARE.SW balance_sheet (annual, 2022-12-31) — Total Assets: 35735429731.71
JCARE.SW balance_sheet (annual, 2022-12-31) — Total Capitalization: 16352799414.10
JCARE.SW balance_sheet (annual, 2022-12-31) — Total Debt: 5443454404.99
JCARE.SW balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 22020374319.08
JCARE.SW income_statement (annual, 2022-12-31) — Total Expenses: 13847517787.13
JCARE.SW balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 13715055412.63
JCARE.SW balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 12557922695.06
JCARE.SW balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 3960057680.87
JCARE.SW income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 3479935793.66
JCARE.SW income_statement (annual, 2022-12-31) — Total Other Finance Cost: 8475722.01
JCARE.SW balance_sheet (annual, 2022-12-31) — Total Tax Payable: 337702273.73
JCARE.SW income_statement (annual, 2022-12-31) — Total Unusual Items: -223107694.75
JCARE.SW income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -223107694.75
JCARE.SW balance_sheet (annual, 2022-12-31) — Treasury Stock: 347176561.29
JCARE.SW balance_sheet (annual, 2022-12-31) — Work In Process: 583879928.26
JCARE.SW balance_sheet (annual, 2022-12-31) — Working Capital: 13422509304.89
JCARE.SW income_statement (annual, 2022-12-31) — Write Off: 4123743.37
JCARE.SW income_statement (annual, 2023-12-31) — +Operating Expense: 6970829199.50
JCARE.SW income_statement (annual, 2023-12-31) — +Total Revenue: 16646350349.72
JCARE.SW balance_sheet (annual, 2023-12-31) — Accounts Payable: 2363434530.66
JCARE.SW balance_sheet (annual, 2023-12-31) — Accounts Receivable: 2692941866.24
JCARE.SW balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -6203239540.94
JCARE.SW balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1352404094.10
JCARE.SW balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -86307916.04
JCARE.SW cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 346538742.13
JCARE.SW balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 1155283408.36
JCARE.SW income_statement (annual, 2023-12-31) — Basic Average Shares: 189839437.00
JCARE.SW income_statement (annual, 2023-12-31) — Basic EPS: 7.60
JCARE.SW cash_flow (annual, 2023-12-31) — Beginning Cash Position: 14178465686.40
JCARE.SW cash_flow (annual, 2023-12-31) — Capital Expenditure: -1130148501.91
JCARE.SW balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 15422948.41
JCARE.SW balance_sheet (annual, 2023-12-31) — Capital Stock: 1865523807.00
JCARE.SW balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 15691888314.83
JCARE.SW balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 15774787469.07
JCARE.SW cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -480863790.08
JCARE.SW balance_sheet (annual, 2023-12-31) — Cash Equivalents: 111290519.82
JCARE.SW balance_sheet (annual, 2023-12-31) — Cash Financial: 15580597795.01
JCARE.SW cash_flow (annual, 2023-12-31) — Cash Flowsfromusedin Operating Activities Direct: 3928909609.73
JCARE.SW cash_flow (annual, 2023-12-31) — Change In Inventory: -415385285.01
JCARE.SW cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -25723917.47
JCARE.SW cash_flow (annual, 2023-12-31) — Change In Payable: -7046712674.37
JCARE.SW cash_flow (annual, 2023-12-31) — Change In Receivables: 6974012382.11
JCARE.SW cash_flow (annual, 2023-12-31) — Change In Working Capital: -513809494.74
JCARE.SW cash_flow (annual, 2023-12-31) — Changes In Cash: 1123991750.60
JCARE.SW cash_flow (annual, 2023-12-31) — Classesof Cash Payments: -13671338803.67
JCARE.SW cash_flow (annual, 2023-12-31) — Classesof Cash Receiptsfrom Operating Activities: 19271748646.35
JCARE.SW balance_sheet (annual, 2023-12-31) — Common Stock: 1865523807.00
JCARE.SW balance_sheet (annual, 2023-12-31) — Common Stock Equity: 13755901924.06
JCARE.SW balance_sheet (annual, 2023-12-31) — Construction In Progress: 531059118.06
JCARE.SW income_statement (annual, 2023-12-31) — Cost Of Revenue: 6298465671.11
JCARE.SW balance_sheet (annual, 2023-12-31) — Current Assets: 23874630390.40
JCARE.SW balance_sheet (annual, 2023-12-31) — Current Debt: 2076159347.22
JCARE.SW balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2794723491.53
JCARE.SW balance_sheet (annual, 2023-12-31) — Current Liabilities: 9860687845.52
JCARE.SW cash_flow (annual, 2023-12-31) — Depreciation: 707554652.43
JCARE.SW cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1054093394.56
JCARE.SW income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 135294893.83
JCARE.SW income_statement (annual, 2023-12-31) — Depreciation Income Statement: 135294893.83
JCARE.SW income_statement (annual, 2023-12-31) — Diluted Average Shares: 189839437.00
JCARE.SW income_statement (annual, 2023-12-31) — Diluted EPS: 7.60
JCARE.SW balance_sheet (annual, 2023-12-31) — Dividends Payable: 12478280.13
JCARE.SW income_statement (annual, 2023-12-31) — EBIT: 3612282806.18
JCARE.SW income_statement (annual, 2023-12-31) — EBITDA: 4666376200.74
JCARE.SW cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 38411935.73
JCARE.SW cash_flow (annual, 2023-12-31) — End Cash Position: 15340869372.73
JCARE.SW cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1927493522.28
JCARE.SW balance_sheet (annual, 2023-12-31) — Finished Goods: 1135358364.37
JCARE.SW cash_flow (annual, 2023-12-31) — Free Cash Flow: 2798761107.82
JCARE.SW cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -54054856.89
JCARE.SW cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 2746804.88
JCARE.SW income_statement (annual, 2023-12-31) — General And Administrative Expense: 368667127.72
JCARE.SW balance_sheet (annual, 2023-12-31) — Goodwill: 636339503.82
JCARE.SW balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1803171324.72
JCARE.SW balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 2779249782.28
JCARE.SW balance_sheet (annual, 2023-12-31) — Gross PPE: 12434884282.46
JCARE.SW income_statement (annual, 2023-12-31) — Gross Profit: 10347884678.61
JCARE.SW income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 312369926.37
JCARE.SW income_statement (annual, 2023-12-31) — Interest Expense: 146728005.05
JCARE.SW income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 146728005.05
JCARE.SW income_statement (annual, 2023-12-31) — Interest Income: 532253758.86
JCARE.SW income_statement (annual, 2023-12-31) — Interest Income Non Operating: 532253758.86
JCARE.SW balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: 0.00
JCARE.SW balance_sheet (annual, 2023-12-31) — Inventory: 2655808391.09
JCARE.SW balance_sheet (annual, 2023-12-31) — Invested Capital: 18954334550.27
JCARE.SW cash_flow (annual, 2023-12-31) — Investing Cash Flow: -877424336.85
JCARE.SW balance_sheet (annual, 2023-12-31) — Investment Properties: 16958213.00
JCARE.SW balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 1155283408.36
JCARE.SW cash_flow (annual, 2023-12-31) — Issuance Of Debt: 4273570084.01
JCARE.SW balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 15422948.41
JCARE.SW balance_sheet (annual, 2023-12-31) — Long Term Debt: 3122273278.99
JCARE.SW balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3137696227.40
JCARE.SW cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 4273570084.01
JCARE.SW cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -3390232777.68
JCARE.SW balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 1411036353.95
JCARE.SW balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 6252873807.80
JCARE.SW balance_sheet (annual, 2023-12-31) — Minority Interest: 8883628566.58
JCARE.SW income_statement (annual, 2023-12-31) — Minority Interests: -1408239321.14
JCARE.SW cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -22461951.59
JCARE.SW income_statement (annual, 2023-12-31) — Net Income: 1442779722.23
JCARE.SW income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 1442779722.23
JCARE.SW income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 2851019043.37
JCARE.SW income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 1442779722.23
JCARE.SW income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 1442779722.23
JCARE.SW cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 2851019043.37
JCARE.SW income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 2851019043.37
JCARE.SW income_statement (annual, 2023-12-31) — Net Interest Income: 377592388.54
JCARE.SW cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 436234803.82
JCARE.SW cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 883337306.33
JCARE.SW cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 883337306.33
JCARE.SW income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 377592388.54
JCARE.SW cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1195865613.77
JCARE.SW cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -176352903.78
JCARE.SW balance_sheet (annual, 2023-12-31) — Net PPE: 6231644741.52
JCARE.SW cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1114844285.30
JCARE.SW balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 11952730599.34
JCARE.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 328642740.95
JCARE.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 370179550.82
JCARE.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 579534830.15
JCARE.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 260032144.44
JCARE.SW income_statement (annual, 2023-12-31) — Normalized EBITDA: 5021851029.11
JCARE.SW income_statement (annual, 2023-12-31) — Normalized Income: 1735219335.30
JCARE.SW cash_flow (annual, 2023-12-31) — Operating Cash Flow: 3928909609.73
JCARE.SW income_statement (annual, 2023-12-31) — Operating Income: 3377055479.11
JCARE.SW income_statement (annual, 2023-12-31) — Operating Revenue: 16646350349.72
JCARE.SW balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1865523807.00
JCARE.SW cash_flow (annual, 2023-12-31) — Other Cash Paymentsfrom Operating Activities: -5129312440.93
JCARE.SW cash_flow (annual, 2023-12-31) — Other Cash Receiptsfrom Operating Activities: 886837372.89
JCARE.SW balance_sheet (annual, 2023-12-31) — Other Current Assets: 483778610.45
JCARE.SW balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 51087001.83
JCARE.SW balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1166831820.90
JCARE.SW balance_sheet (annual, 2023-12-31) — Other Inventories: 129288490.05
JCARE.SW cash_flow (annual, 2023-12-31) — Other Non Cash Items: 169444237.62
JCARE.SW balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 957224255.77
JCARE.SW balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 90000000.00
JCARE.SW income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -40341555.06
JCARE.SW income_statement (annual, 2023-12-31) — Other Operating Expenses: 231188930.14
JCARE.SW balance_sheet (annual, 2023-12-31) — Other Payable: 4069592232.51
JCARE.SW balance_sheet (annual, 2023-12-31) — Other Properties: 1005929228.97
JCARE.SW balance_sheet (annual, 2023-12-31) — Other Receivables: 1987211192.61
JCARE.SW balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 82899154.24
JCARE.SW income_statement (annual, 2023-12-31) — Other Special Charges: 169901.01
JCARE.SW income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
JCARE.SW balance_sheet (annual, 2023-12-31) — Payables: 6855707897.39
JCARE.SW cash_flow (annual, 2023-12-31) — Paymentson Behalfof Employees: -2459885718.06
JCARE.SW cash_flow (annual, 2023-12-31) — Paymentsto Suppliersfor Goodsand Services: -6082140644.68
JCARE.SW balance_sheet (annual, 2023-12-31) — Prepaid Assets: 280102860.94
JCARE.SW income_statement (annual, 2023-12-31) — Pretax Income: 3465554801.13
JCARE.SW balance_sheet (annual, 2023-12-31) — Properties: 4645022127.63
JCARE.SW cash_flow (annual, 2023-12-31) — Purchase Of Business: -22461951.59
JCARE.SW cash_flow (annual, 2023-12-31) — Purchase Of Investment: -204656113.68
JCARE.SW cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1130148501.91
JCARE.SW balance_sheet (annual, 2023-12-31) — Raw Materials: 722488606.33
JCARE.SW cash_flow (annual, 2023-12-31) — Receiptsfrom Customers: 18384911273.46
JCARE.SW income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 6298465671.11
JCARE.SW income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1054093394.56
JCARE.SW cash_flow (annual, 2023-12-31) — Repayment Of Debt: -3390232777.68
JCARE.SW income_statement (annual, 2023-12-31) — Research And Development: 1661757980.90
JCARE.SW balance_sheet (annual, 2023-12-31) — Retained Earnings: 9441857956.80
JCARE.SW cash_flow (annual, 2023-12-31) — Sale Of Investment: 640890917.50
JCARE.SW cash_flow (annual, 2023-12-31) — Sale Of PPE: 15304216.61
JCARE.SW income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 3932401834.11
JCARE.SW income_statement (annual, 2023-12-31) — Selling General And Administration: 4301068961.83
JCARE.SW balance_sheet (annual, 2023-12-31) — Share Issued: 1865523807.00
JCARE.SW income_statement (annual, 2023-12-31) — Special Income Charges: -329386295.94
JCARE.SW balance_sheet (annual, 2023-12-31) — Stockholders Equity: 13755901924.06
JCARE.SW balance_sheet (annual, 2023-12-31) — Tangible Book Value: 11952730599.34
JCARE.SW income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -63035215.30
JCARE.SW income_statement (annual, 2023-12-31) — Tax Provision: 614535757.76
JCARE.SW income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.18
JCARE.SW cash_flow (annual, 2023-12-31) — Taxes Refund Paid Direct: -1671500232.95
JCARE.SW balance_sheet (annual, 2023-12-31) — Total Assets: 36358126258.82
JCARE.SW balance_sheet (annual, 2023-12-31) — Total Capitalization: 16878175203.05
JCARE.SW balance_sheet (annual, 2023-12-31) — Total Debt: 5932419718.93